Streetbeat News

Products Services

AGEN

MPLN

The article highlights MultiPlan Corporation (NYSE:MPLN) and Agenus Inc. (NASDAQ:AGEN) as the top 2 oversold health care stocks, suggesting potential investment opportunities. MPLN announced its Q1 2024 financial results release for May 8, 2024, after a recent 18% stock decline. AGEN reported positive Phase 1 trial results for a cancer therapy, following a 48% stock decrease over the past month. Both stocks have an RSI below 30, indicating they may be undervalued.

Portfolio Pulse from Avi Kapoor

April 23, 2024 | 12:36 pm

NEGG

Newegg has introduced a new membership program called Newegg+, offering benefits such as free shipping, early access to new products, and exclusive deals to its members. This initiative aims to enhance customer loyalty and increase sales by providing added value to the shopping experience on Newegg's platform.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:36 pm

CDXC

ChromaDex has announced that its flagship product, Tru Niagen, is now available at Sprouts Farmers Market. This marks Tru Niagen's first major grocery debut, potentially expanding its market reach and consumer base.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:36 pm

ADEA

Adeia has renewed its intellectual property licensing agreement with Altimedia for multiple years, though the financial details of the deal have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:35 pm

SVM

Silvercorp Metals Inc. forecasts production of 7,900 to 9,000 ounces of gold, 6.8 to 7.2 million ounces of silver, 64.2 to 69.3 million pounds of lead, and 27.1 to 30.1 million pounds of zinc for the fiscal year 2025.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:34 pm

BLIN

Bridgeline Digital, Inc. (NASDAQ:BLIN) has announced a partnership with Springthrough Agency to use Bridgeline's HawkSearch AI technology for enhancing eCommerce websites on the Sitefinity platform, aiming to increase revenue.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:34 pm

PALI

Palisade Bio has entered into a collaboration with Strand Life Sciences to advance precision medicine approaches. This partnership grants Palisade Bio access to advanced bioinformatics tools, potentially enhancing its research and development capabilities in the field of precision medicine.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:33 pm

OND

SOCL

SPOT

Spotify Technology SA (NYSE:SPOT) reported a 20% year-on-year revenue growth for Q1 2024, reaching €3.64 billion ($3.95 billion), surpassing the consensus of $3.85 billion. EPS was €0.97 ($1.05), beating the consensus of $0.70. Premium revenue and subscribers grew by 20% and 14% respectively, with ARPU increasing by 5%. However, total MAUs of 615 million fell short of guidance by 3 million. The company cited moderated marketing activity and recent layoffs as factors. Ad-supported MAUs and revenue saw significant growth. Gross margin improvements were noted across the board, with operating income hitting a new quarterly high of €168 million. Spotify expects Q2 revenue of €3.8 billion and 631 million MAUs. SPOT shares rose 8.27% in premarket trading. Investors can also gain exposure through Global X Social Media ETF (NASDAQ:SOCL) and ProShares On-Demand ETF (NYSE:OND).

Portfolio Pulse from Anusuya Lahiri

April 23, 2024 | 12:33 pm

KULR

KULR Technology Group Inc. has fulfilled an urgent order for power cell batteries to support AI-enabled drone missions in Ukraine. This deployment underscores the company's role in providing critical technology for defense and intelligence applications.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:32 pm

CYBR

CyberArk has launched a UAE-hosted Identity Security Platform, enhancing its support for the data sovereignty needs of key industries in the region. This move demonstrates CyberArk's commitment to helping UAE organizations protect against attacks on human and machine identities.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:27 pm